IAG . Bankinter Fija su Precio Objetivo en 3,50€ Por Acción . En Marcha la Recompra de Acciones .
31 agosto 2018
Trabectedin for soft-tissue sarcoma safe, effective in elderly patients .
This subgroup analysis of the elderly population of ET743-SAR-3007 suggests that elderly patients with soft tissue sarcoma and good performance status can expect clinical benefit from trabectedin similar to that observed in younger patients. ...
‹
›
Inicio
Ver versión web